Current perspectives in autism spectrum disorder: From genes to therapy

Maria Chahrour, Brian J. O’Roak, Emanuela Santini, Rodney C. Samaco, Robin J. Kleiman, M. Chiara Manzini

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Autism spectrum disorder (ASD) is a constellation of neurodevelopmental presentations with high heritability and both phenotypic and genetic heterogeneity. To date, mutations in hundreds of genes have been associated to varying degrees with increased ASD risk. A better understanding of the functions of these genes and whether they fit together in functional groups or impact similar neuronal circuits is needed to develop rational treatment strategies.Wewill review current areas of emphasis in ASD research, starting from human genetics and exploring how mouse models of human mutations have helped identify specific molecular pathways (protein synthesis and degradation, chromatin remodeling, intracellular signaling), which are linked to alterations in circuit function and cognitive/social behavior. We will conclude by discussing how we can leverage the findings on molecular and cellular alterations found in ASD to develop therapies for neurodevelopmental disorders.

Original languageEnglish (US)
Pages (from-to)11402-11410
Number of pages9
JournalJournal of Neuroscience
Volume36
Issue number45
DOIs
StatePublished - Nov 9 2016

Fingerprint

Genetic Therapy
Mutation
Chromatin Assembly and Disassembly
Genetic Heterogeneity
Social Behavior
Medical Genetics
Cognition
Proteolysis
Genes
Autism Spectrum Disorder
Therapeutics
Research

Keywords

  • Animal models
  • Autism spectrum disorder
  • Genetics
  • Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Chahrour, M., O’Roak, B. J., Santini, E., Samaco, R. C., Kleiman, R. J., & Manzini, M. C. (2016). Current perspectives in autism spectrum disorder: From genes to therapy. Journal of Neuroscience, 36(45), 11402-11410. https://doi.org/10.1523/JNEUROSCI.2335-16.2016

Current perspectives in autism spectrum disorder : From genes to therapy. / Chahrour, Maria; O’Roak, Brian J.; Santini, Emanuela; Samaco, Rodney C.; Kleiman, Robin J.; Manzini, M. Chiara.

In: Journal of Neuroscience, Vol. 36, No. 45, 09.11.2016, p. 11402-11410.

Research output: Contribution to journalArticle

Chahrour, M, O’Roak, BJ, Santini, E, Samaco, RC, Kleiman, RJ & Manzini, MC 2016, 'Current perspectives in autism spectrum disorder: From genes to therapy', Journal of Neuroscience, vol. 36, no. 45, pp. 11402-11410. https://doi.org/10.1523/JNEUROSCI.2335-16.2016
Chahrour, Maria ; O’Roak, Brian J. ; Santini, Emanuela ; Samaco, Rodney C. ; Kleiman, Robin J. ; Manzini, M. Chiara. / Current perspectives in autism spectrum disorder : From genes to therapy. In: Journal of Neuroscience. 2016 ; Vol. 36, No. 45. pp. 11402-11410.
@article{4d9f49c4e90a471f837af846e172dd57,
title = "Current perspectives in autism spectrum disorder: From genes to therapy",
abstract = "Autism spectrum disorder (ASD) is a constellation of neurodevelopmental presentations with high heritability and both phenotypic and genetic heterogeneity. To date, mutations in hundreds of genes have been associated to varying degrees with increased ASD risk. A better understanding of the functions of these genes and whether they fit together in functional groups or impact similar neuronal circuits is needed to develop rational treatment strategies.Wewill review current areas of emphasis in ASD research, starting from human genetics and exploring how mouse models of human mutations have helped identify specific molecular pathways (protein synthesis and degradation, chromatin remodeling, intracellular signaling), which are linked to alterations in circuit function and cognitive/social behavior. We will conclude by discussing how we can leverage the findings on molecular and cellular alterations found in ASD to develop therapies for neurodevelopmental disorders.",
keywords = "Animal models, Autism spectrum disorder, Genetics, Therapeutics",
author = "Maria Chahrour and O’Roak, {Brian J.} and Emanuela Santini and Samaco, {Rodney C.} and Kleiman, {Robin J.} and Manzini, {M. Chiara}",
year = "2016",
month = "11",
day = "9",
doi = "10.1523/JNEUROSCI.2335-16.2016",
language = "English (US)",
volume = "36",
pages = "11402--11410",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "45",

}

TY - JOUR

T1 - Current perspectives in autism spectrum disorder

T2 - From genes to therapy

AU - Chahrour, Maria

AU - O’Roak, Brian J.

AU - Santini, Emanuela

AU - Samaco, Rodney C.

AU - Kleiman, Robin J.

AU - Manzini, M. Chiara

PY - 2016/11/9

Y1 - 2016/11/9

N2 - Autism spectrum disorder (ASD) is a constellation of neurodevelopmental presentations with high heritability and both phenotypic and genetic heterogeneity. To date, mutations in hundreds of genes have been associated to varying degrees with increased ASD risk. A better understanding of the functions of these genes and whether they fit together in functional groups or impact similar neuronal circuits is needed to develop rational treatment strategies.Wewill review current areas of emphasis in ASD research, starting from human genetics and exploring how mouse models of human mutations have helped identify specific molecular pathways (protein synthesis and degradation, chromatin remodeling, intracellular signaling), which are linked to alterations in circuit function and cognitive/social behavior. We will conclude by discussing how we can leverage the findings on molecular and cellular alterations found in ASD to develop therapies for neurodevelopmental disorders.

AB - Autism spectrum disorder (ASD) is a constellation of neurodevelopmental presentations with high heritability and both phenotypic and genetic heterogeneity. To date, mutations in hundreds of genes have been associated to varying degrees with increased ASD risk. A better understanding of the functions of these genes and whether they fit together in functional groups or impact similar neuronal circuits is needed to develop rational treatment strategies.Wewill review current areas of emphasis in ASD research, starting from human genetics and exploring how mouse models of human mutations have helped identify specific molecular pathways (protein synthesis and degradation, chromatin remodeling, intracellular signaling), which are linked to alterations in circuit function and cognitive/social behavior. We will conclude by discussing how we can leverage the findings on molecular and cellular alterations found in ASD to develop therapies for neurodevelopmental disorders.

KW - Animal models

KW - Autism spectrum disorder

KW - Genetics

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=84994751900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994751900&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.2335-16.2016

DO - 10.1523/JNEUROSCI.2335-16.2016

M3 - Article

C2 - 27911742

AN - SCOPUS:84994751900

VL - 36

SP - 11402

EP - 11410

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 45

ER -